10
M.H. Katcher, T.F. Jamison / Tetrahedron xxx (2018) 1e12
1H), 3.74 (dd, J ¼ 11.4, 5.0 Hz, 1H), 3.67e3.59 (m, 2H), 3.49 (d,
J ¼ 8.5 Hz, 1H), 3.44e3.41 (m, 1H), 3.38 (s, 6H), 3.37e3.28 (m, 3H),
3.23 (s, 3H), 3.14e3.00 (m, 3H), 2.95 (dd, J ¼ 7.6, 4.5 Hz,1H), 2.48 (dt,
J ¼ 11.8, 4.3 Hz, 1H), 2.27 (dd, J ¼ 11.4, 4.2 Hz, 1H), 1.94e1.82 (m, 2H),
1.75e1.66 (m, 2H), 1.65e1.54 (m, 3H), 1.39 (s, 3H), 1.35 (s, 3H), 1.31
(s, 3H), 1.16 (s, 3H), 0.87 (s, 9H), 0.11 (s, 6H). 13C NMR (126 MHz,
2% triethylamine, then 0 / 10% methanol in ethyl acetate) to afford
the title compound (39.0 mg, 0.0612 mmol, 83% yield) as a colorless
oil. This compound was stored frozen in benzene at ꢀ20 ꢁC to avoid
decomposition. 1H NMR (500 MHz, CDCl3)
d 7.38e7.29 (m, 5H), 4.72
(d, J ¼ 11.3 Hz, 1H), 4.69e4.63 (m, 2H), 4.52 (d, J ¼ 11.3 Hz, 1H),
3.80e3.74 (m, 1H), 3.73 (dd, J ¼ 11.3, 4.8 Hz, 1H), 3.66e3.61 (m, 2H),
3.51e3.48 (m, 2H), 3.42e3.30 (m, 9H), 3.23 (s, 3H), 3.11e2.94 (m,
5H), 2.49 (ddd, J ¼ 11.7, 4.4, 4.4 Hz,1H), 2.26 (dd, J ¼ 11.5, 4.4 Hz,1H),
1.82e1.78 (m, 2H), 1.74e1.71 (m, 1H), 1.62e1.47 (m, 3H), 1.39 (s, 3H),
1.35 (s, 3H), 1.35 (s, 3H), 1.15 (s, 3H). 13C NMR (125 MHz, CDCl3)
CDCl3)
d 96.73, 82.64, 82.05, 78.27, 76.49, 76.37, 71.85, 71.45, 66.23,
61.30, 60.14, 59.76, 59.45, 59.20, 59.12, 57.84, 55.52, 49.17, 40.26,
39.48, 37.93, 37.44, 25.84, 18.26, 18.00, 17.31, 17.13,
12.73, ꢀ3.54, ꢀ4.77 (one ethereal carbon likely under solvent peak).
FT-IR (ATR, cmꢀ1): 2931, 2886, 2859, 1460, 1387, 1252, 1090, 1039,
955, 916, 862, 836, 777, 729. HRMS (ESI, m/z): calculated for
d
146.45, 137.25, 128.81, 128.38, 128.16, 109.90, 96.74, 84.61, 82.56,
80.98, 76.50, 76.24, 74.09, 73.36, 71.45, 68.61, 66.17, 61.30, 60.27,
59.44, 59.42, 59.14, 58.99, 58.44, 55.53, 49.14, 40.26, 37.66, 18.27,
17.21, 17.18, 13.84. FT-IR (ATR, cmꢀ1): 2923, 2854, 1456, 1377, 1208,
C
33H60NaO11Si
([MþNa]þ):
683.3803,
found:
683.3811.
20
[
a
]
¼ ꢀ17.0 (c ¼ 1.08, CHCl3).
D
1086, 1040, 955, 920, 868, 752, 699. HRMS (ESI, m/z): calculated for
20
4.13. (((2R,3S,4aR,6S,7R,8aS)-2-((S)-(benzyloxy)((2R,3S)-3-
(((2S,3S)-3-(((2S,3S)-3-((methoxymethoxy)methyl)-2-
methyloxiran-2-yl)methyl)-2-methyloxiran-2-yl)methyl)-2-
C
34H52NaO11 ([MþNa]þ): 659.3407, found: 659.3405. [
a
]
¼ ꢀ60.
D
(c ¼ 0.12, CHCl3).
methyloxiran-2-yl)methyl)-7-methoxy-6-(methoxymethyl)-7-
methyloctahydropyrano[3,2-b]pyran-3-yl)oxy)(tert-butyl)
dimethylsilane (24)
4.15. Procedure for cyclization with KHMDS
To a solution of alcohol 3 (1.0 mg, 0.00157 mmol) in THF (125 mL)
at ꢀ78 ꢁC under argon, a solution of potassium bis(trimethylsilyl)
To a solution of triepoxide 23 (105 mg, 0.159 mmol, 5:1 dr) in
benzyl bromide (1.08 mL) at room temperature, tetra-n-buty-
lammonium iodide (5.9 mg, 0.0159 mmol) was added. After stirring
at room temperature for 5 min, silver(I) oxide (368 mg, 1.59 mmol)
was added. The reaction mixture was allowed to stir at room
temperature for 4.5 h before filtering through a short plug of Celite,
eluting with diethyl ether. The filtrate was concentrated under
reduced pressure, and the residue was purified by Biotage auto-
mated chromatography (10 g Ultra silica gel,10 / 80% ethyl acetate
in hexanes) to afford the title compound (98.0 mg, 99% w/w with
ethyl acetate, 0.129 mmol, 81% yield, 5:1 dr, major/all other di-
astereomers) as a colorless oil. 1H NMR (500 MHz, CDCl3, undesired
amide (3.1 mg, 0.0157 mmol) in THF (30 mL) was added dropwise
via syringe. After stirring at ꢀ78 ꢁC for 5 min, the reaction mixture
was transferred to an ice/water bath. After stirring at 0 ꢁC for 8 h,
the reaction mixture was allowed to stir overnight as the cooling
bath expired. The mixture was then quenched with aqueous
ammonium chloride (saturated). The aqueous layer was extracted
with ethyl acetate (4ꢃ). The combined organic extracts were
washed with brine, dried over sodium sulfate, filtered, and
concentrated under reduced pressure. The residue was dissolved in
benzene-d6 for analysis by 1H NMR spectroscopy. A 3:1 ratio of 25/
26 was observed.
diastereomer indicated by * where visible)
d
7.41e7.27 (m, 5H),
4.15.1. (2R,3R,4S,4aS,5aS,7R,8S,9aR,10aS)-4-(benzyloxy)-7-
methoxy-2-(((2S,3S)-3-(((2S,3S)-3-((methoxymethoxy)methyl)-2-
methyloxiran-2-yl)methyl)-2-methyloxiran-2-yl)methyl)-8-
(methoxymethyl)-3,7-dimethyldecahydro-2H-dipyrano[3,2-b:20,30-
e]pyran-3-ol (25)
4.71e4.64 (m, 2H), 4.61 (d, J ¼ 12.5 Hz, 1H), 4.54 (d, J ¼ 12.5 Hz, 1H),
3.91 (td, J ¼ 10.2, 4.9 Hz, 1H), 3.74 (dd, J ¼ 11.5, 4.9 Hz, 1H),
3.67e3.59 (m, 2H), 3.55e3.45 (m, 2H), 3.38 (s, 3H), 3.38 (s, 3H),
3.37e3.33 (m, 1H), 3.28e3.24 (m, 1H), 3.23 (s, 3H), 3.10e2.97 (m,
3H), 2.93 (dd, J ¼ 7.2, 4.9 Hz, 1H), 2.61 (dd, J ¼ 8.4, 3.1 Hz, 1H), 2.43
(ddd, J ¼ 11.6, 4.2, 4.2 Hz, 1H), 2.37 (dd, J ¼ 11.3, 3.9 Hz, 1H), 1.83 (dd,
J ¼ 14.5, 4.9 Hz, 1H), 1.77e1.69 (m, 2H), 1.60e1.40 (m, 4H), 1.39 (s,
3H), 1.38 (s, 3H), 1.29 (s, 3H), 1.14 (s, 3H), 0.85 (s, 9H*), 0.75 (s, 9H),
0.09 (s, 3H*), 0.07 (s, 3H*), 0.02 (s, 3H), ꢀ0.08 (s, 3H). 13C NMR
1H NMR (500 MHz, C6D6)
d 7.26e7.23 (m, 2H), 7.15e7.04 (m, 3H),
4.96 (d, J ¼ 11.6 Hz, 1H), 4.51 (s, 2H), 4.48 (d, J ¼ 11.6 Hz, 1H), 3.79 (d,
J ¼ 10.2 Hz, 1H), 3.71 (dd, J ¼ 10.7, 4.3 Hz, 1H), 3.69e3.59 (m, 4H),
3.49 (dd, J ¼ 11.4, 5.4 Hz, 1H), 3.35 (dd, J ¼ 10.3, 8.0 Hz, 1H), 3.21 (d,
J ¼ 0.7 Hz, 3H), 3.20 (d, J ¼ 0.9 Hz, 3H), 3.20e3.18 (m, 1H), 3.15 (dd,
J ¼ 10.1, 2.6 Hz, 1H), 3.03 (dd, J ¼ 5.5, 5.5 Hz, 1H), 2.94 (d, J ¼ 0.6 Hz,
3H), 2.91e2.79 (m, 3H), 2.59 (ddd, J ¼ 11.0, 4.0, 4.0 Hz, 1H), 2.14 (d,
J ¼ 14.7 Hz, 1H), 2.10 (dd, J ¼ 11.3, 3.9 Hz, 1H), 1.88 (dd, J ¼ 14.9,
9.7 Hz, 1H), 1.77 (dd, J ¼ 14.3, 5.6 Hz, 1H), 1.65 (dd, J ¼ 14.4, 6.9 Hz,
1H),1.56 (dd, J ¼ 11.3,11.2 Hz,1H),1.47 (dd, J ¼ 11.2,11.2 Hz,1H),1.25
(s, 3H), 1.20 (s, 3H), 1.13 (s, 3H), 1.01 (s, 3H). 13C NMR (126 MHz,
(126 MHz, CDCl3)
d 138.21, 128.72, 128.61, 128.09, 127.99, 96.75,
85.96, 82.48, 79.23, 76.62, 76.26, 74.10, 71.76, 71.56, 67.17, 66.21,
61.29, 60.05, 59.89, 59.41, 59.22, 59.10, 55.52, 49.10, 40.32, 39.83,
37.86, 25.87, 18.13, 17.92, 17.20, 17.03, 14.36, ꢀ3.97, ꢀ4.92. FT-IR
(ATR, cmꢀ1): 2930, 2884, 2858, 1456, 1375, 1329, 1250, 1088, 1043,
917, 870, 836, 776, 731, 698. HRMS (ESI, m/z): calculated for
C
40H66NaO11Si
([MþNa]þ):
773.4272,
found:
773.4257.
C6D6) d 138.90,128.78, 96.74, 83.50, 82.58, 80.29, 77.32, 77.21, 76.76,
20
[
a
]
¼ ꢀ25.5 (c ¼ 0.523, CHCl3).
75.08, 74.09, 71.86, 71.39, 70.56, 66.49, 60.90, 59.11, 58.94, 58.69,
58.69, 55.07, 48.64, 40.95, 37.78, 36.37, 35.75, 19.33, 19.27, 18.18,
17.30 (two aromatic carbons likely under solvent peaks). FT-IR
(ATR, cmꢀ1): 2924, 2854, 1458, 1377, 1333, 1211, 1101, 1039, 936,
D
4.14. (2S,3S,4aR,6S,7R,8aS)-2-((S)-(benzyloxy)((2R,3S)-3-(((2S,3S)-
3-(((2S,3S)-3-((methoxymethoxy)methyl)-2-methyloxiran-2-yl)
methyl)-2-methyloxiran-2-yl)methyl)-2-methyloxiran-2-yl)
methyl)-7-methoxy-6-(methoxymethyl)-7-methyloctahydropyrano
[3,2-b]pyran-3-ol (3)
920, 741, 698. HRMS (ESI, m/z): calculated for
C
34H52NaO11
20
([MþNa]þ): 659.3407, found: 659.3402. [
a]
¼ ꢀ10. (c ¼ 0.090,
D
CHCl3).
To a solution of benzyl ether 24 (55.7 mg, 0.0742 mmol) in THF
4.15.2. (2R,3R,4S,4aS,5aS,7R,8S,9aR,10aS)-4-(benzyloxy)-2-((S)-2-
hydroxy-2-((2R,5S)-5-((methoxymethoxy)methyl)-4-methyl-2,5-
dihydrofuran-2-yl)propyl)-7-methoxy-8-(methoxymethyl)-3,7-
dimethyldecahydro-2H-dipyrano[3,2-b:20,30-e]pyran-3-ol (26)
(750
(222
m
L) at room temperature, tetra-n-butylammonium fluoride
mL, 1 M in THF, 0.222 mmol) was added. After stirring at room
temperature for 2 h, the reaction mixture was then loaded directly
onto a column for purification by Biotage automated chromatog-
raphy (10 g Ultra silica gel, 20 / 100% ethyl acetate in hexanes with
1H NMR (500 MHz, C6D6)
d
7.30e7.22 (m, 3H), 7.18e7.05 (m, 2H),
5.78 (d, J ¼ 1.8 Hz, 1H), 4.98e4.94 (m, 2H), 4.73 (d, J ¼ 2.5 Hz, 1H),
Please cite this article in press as: Katcher MH, Jamison TF, Studies toward brevisulcenal F via convergent strategies for marine ladder polyether